Lupkynis (voclosporin) - Aurinia Pharma
Real-World Use of Voclosporin in Lupus Nephritis (LUPUS 2026) - Feb 17, 2026 - Abstract #PO:13:335; 5; Pres time: Mar 6, 2026; 07:30 AM - 07:30 PM; Location: Poster Area; "However, the patient developed hypertension after voclosporin initiation, requiring closer blood pressure monitoring. Our real-world use of voclosporin outside a clinical trial setting shows positive renal outcomes similar to those demonstrated in large-scale trials and enables dose reduction in steroids." 
Clinical • Real-world • Real-world evidence • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis
https://lupus.bmj.com/content/13/Suppl_1/A324
 
Khoanh Iien Nhuien; Luxme Nadarajah; Andrea Cove-Smith; Dev Pyne; Angela Pakozdi; Malvina Cunningham; Sarah Mehren; Ravindra Rajakariar
 
Feb 17, 2026
 
Prev Next